Pulmonx
Ludivine Steffen has a diverse background in customer service and administrative roles, currently serving as a Représentant service client at Pulmonx Corporation since November 2022. Prior experience includes working as a Secrétaire du laboratoire at Medistri SA from October 2021 to September 2022, and as a Conseillère financière junior at Swiss Life Select from January 2020 to August 2021. Ludivine's career began at SUSS MicroOptics, where roles included Assistante achats and Assistante back-office from July 2017 to July 2019. Educationally, Ludivine holds a CFC in Employée de commerce, with a focus on Comptabilité et commerce/gestion from Lycée Jean-Piaget, completed in 2016.
This person is not in any offices
Pulmonx
2 followers
Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1